New Fixed-Dose Artesunate-Mefloquine Formulation Against Multidrug-Resistant Plasmodium Falciparum in Adults: A Comparative Phase IIb Safety and Pharmacokinetic Study With Standard-Dose Nonfixed Artesunate Plus Mefloquine
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01187-09
Full Text
Open PDFAbstract
Available in full text
Date
June 14, 2010
Authors
Publisher
American Society for Microbiology